Compare OWLT & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OWLT | STIM |
|---|---|---|
| Founded | 2013 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.8M | 120.4M |
| IPO Year | 2020 | 2018 |
| Metric | OWLT | STIM |
|---|---|---|
| Price | $4.53 | $2.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $13.00 | $5.75 |
| AVG Volume (30 Days) | 109.0K | ★ 706.4K |
| Earning Date | 11-16-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 57.25 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $105,708,000.00 | $52,776,000.00 |
| Revenue This Year | $13.29 | $8.63 |
| Revenue Next Year | $20.39 | $9.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 35.43 | N/A |
| 52 Week Low | $4.02 | $0.80 |
| 52 Week High | $16.94 | $3.44 |
| Indicator | OWLT | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 42.73 | 50.95 |
| Support Level | N/A | $1.92 |
| Resistance Level | $6.08 | $2.40 |
| Average True Range (ATR) | 0.19 | 0.16 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 42.00 | 65.62 |
Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.